The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Share News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brazilian waste management firm finds cost-cutting users in pandemic

Thu, 16th Jul 2020 22:34

By Tatiana Bautzer

SAO PAULO, July 16 (Reuters) - A month-old Brazilian
company's machines that use bacteria to break down organic waste
has found users among domestic upscale supermarket Natural da
Terra, units of Reckitt Benckiser and Siemens AG
, and logistics firm Luft, its chief executive said on
Thursday.

Bioconverter, which launched in June as companies sought to
cut waste management costs during the pandemic, is in talks to
lease its machines to other supermarket chains in Brazil and
Mexico, said CEO and founder Nelson Libbos, one of the company's
nine partners, in an interview.

The company may also enter the U.S. market, where some
states are expected to begin restricting organic waste disposal,
he added.

"Companies need to cut costs in the COVID pandemic, and
waste management of organic residues is expensive," Libbos said.

Bioconverter uses bacteria to transform food and other
organic matter into water that may be discarded in sewage
systems or used in agricultural irrigation, complying with
environmental regulations. A bacteria mix is used in its
machines to degrade organic residue within 24 hours.

Processing waste where it is produced reduces costs that
usually include refrigerating the residues before transportation
and the cost of trucks to send it to landfills.

Bioconverter was planning its launch early this year when
the COVID pandemic hit Brazil.

All Bioconverter shareholders have healthcare careers.
Libbos, for example, has headed subsidiaries of international
firms in Brazil, such as Teva Pharmaceutical Industries
. Dirceu Barbano has led Anvisa, Brazil's top health
regulator, and Jose Roberto Corrales owns a drug and health
products distributor.

(Reporting by Tatiana Bautzer; Editing by Richard Chang)

More News
29 Jun 2020 09:29

UK BROKER RATINGS SUMMARY: Jefferies Cuts Balfour Beatty To Hold

UK BROKER RATINGS SUMMARY: Jefferies Cuts Balfour Beatty To Hold

Read more
29 Jun 2020 07:29

Indivior appoints Mark Crossley as CEO after Shaun Thaxter steps down

LONDON, June 29 (Reuters) - British drugmaker Indivior said on Monday it had appointed Mark Crossley as chief executive to replace Shaun Thaxter, who had stepped down in mutual agreement with the board.Crossley has been chief financial officer of ...

Read more
26 Jun 2020 09:37

UPDATE 2-FTSE 100 gains on defensive rally, ends week lower on virus worries

(For a live blog on European stocks, type LIVE/ in an Eikon news window)* BAT, Unilever, Tesco biggest boost to FTSE 100* Pound slides on EU trade deal doubts* Aston Martin slumps on weak outlook, stock offering* FTSE 100 up 0.2%, FTSE 250 up 0.01% ...

Read more
26 Jun 2020 09:21

UK BROKER RATINGS SUMMARY: JPMorgan Raises Rentokil Initial And Bunzl

UK BROKER RATINGS SUMMARY: JPMorgan Raises Rentokil Initial And Bunzl

Read more
23 Jun 2020 13:27

Tuesday broker round-up

(Sharecast News) - Scapa Group: Berenberg reiterates buy with a target price of 150p.

Read more
23 Jun 2020 09:27

UK BROKER RATINGS SUMMARY: Berenberg Likes Direct Line And Hastings

UK BROKER RATINGS SUMMARY: Berenberg Likes Direct Line And Hastings

Read more
16 Jun 2020 09:33

UK BROKER RATINGS SUMMARY: Berenberg Cuts Big Yellow To Hold From Buy

UK BROKER RATINGS SUMMARY: Berenberg Cuts Big Yellow To Hold From Buy

Read more
4 Jun 2020 09:33

UK BROKER RATINGS SUMMARY: Morgan Stanley Upgrades Smith & Nephew

UK BROKER RATINGS SUMMARY: Morgan Stanley Upgrades Smith & Nephew

Read more
3 Jun 2020 16:37

UPDATE 1-UK doctors to trial ibuprofen in COVID-19 patients with breathing difficulties

(Adds interview with researcher)LONDON, June 3 (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19.The trial involves a partic...

Read more
3 Jun 2020 10:54

UK doctors to trial ibuprofen in COVID-19 patients with breathing difficulties

LONDON, June 3 (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19.The trial involves a particular formulation of ibuprofen, ...

Read more
29 May 2020 09:31

UK BROKER RATINGS SUMMARY: Barclays Lowers Admiral, Raises Direct Line

UK BROKER RATINGS SUMMARY: Barclays Lowers Admiral, Raises Direct Line

Read more
12 May 2020 18:22

Reckitt Benckiser Non-Executive Director Steps Down After Ten Years

Reckitt Benckiser Non-Executive Director Steps Down After Ten Years

Read more
12 May 2020 06:57

Moody's Assigns A3 To New Reckitt Benckiser Notes, Outlook Negative

Moody's Assigns A3 To New Reckitt Benckiser Notes, Outlook Negative

Read more
5 May 2020 15:56

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
4 May 2020 13:34

Monday broker round-up

(Sharecast News) - Go-Ahead Group: Canaccord upgrades to buy with a target price of 1,650p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.